Report date: Nov 6,2024
Conflict count: 361874
Publisher: Elsevier
Title count: 938
Conflict count: 15239


==========================================================

Created: 2020-02-27 12:49:39
ConfID: 5579095
CauseID: 1464121798
OtherID: 1347740506
JT: Annals of Oncology
MD: Punt,13,7,1161,2002,D.P. Kelsen, J.M. Daly, S.E. Kern, B. Levin, J.E. Tepper (eds). Gastrointestinal Oncology, Principles and Practice
DOI: 10.1093/oxfordjournals.annonc.a000324(Journal) (5579095-N)
DOI: 10.1093/annonc/mdf182(Journal)
==========================================================

Created: 2020-02-27 12:49:35
ConfID: 5579094
CauseID: 1464121780
OtherID: 1347740507
JT: Annals of Oncology
MD: Wheatley,13,8,1319,2002,Adjuvant interferon for melanoma
DOI: 10.1093/oxfordjournals.annonc.a000325(Journal) (5579094-N)
DOI: 10.1093/annonc/mdf224(Journal)
==========================================================

Created: 2020-05-18 20:28:34
ConfID: 5613485
CauseID: 1469723852
OtherID: 1469723848
JT: Annals of Oncology
MD: Stanczak,28,,418,2017,Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy
DOI: 10.1093/annonc/mdx376.045(Journal) (5613485-N)
DOI: 10.1093/annonc/mdx376.046(Journal)
==========================================================

Created: 2020-05-18 20:28:09
ConfID: 5613484
CauseID: 1469723830
OtherID: 1469723829
JT: Annals of Oncology
MD: Nguyen,28,,414,2017,Melanoma brain metastases patients treated with stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone: a systematic review with meta-analysis
DOI: 10.1093/annonc/mdx376.033(Journal) (5613484-N)
DOI: 10.1093/annonc/mdx376.032(Journal)
==========================================================

Created: 2020-05-18 20:29:14
ConfID: 5613487
CauseID: 1469723882
OtherID: 1469723879
JT: Annals of Oncology
MD: Wilkins,28,,426,2017,A first-in-human, open-label, multicenter phase 1/2a study to evaluate the safety and efficacy of increased repeated doses of the first in class RORγ agonist LYC-55716 in treating locally advanced or metastatic solid tumors
DOI: 10.1093/annonc/mdx376.069(Journal) (5613487-N)
DOI: 10.1093/annonc/mdx376.070(Journal)
==========================================================

Created: 2020-05-18 20:29:09
ConfID: 5613486
CauseID: 1469723878
OtherID: 1469723877
JT: Annals of Oncology
MD: Ott,28,,425,2017,An open-label, Phase IB study of NEO-PV-01 + Adjuvant with Nivolumab in Patients with Melanoma, Non-Small Cell Lung Carcinoma, or Transitional Cell Carcinoma of the Bladder
DOI: 10.1093/annonc/mdx376.068(Journal) (5613486-N)
DOI: 10.1093/annonc/mdx376.067(Journal)
==========================================================

Created: 2020-05-18 20:27:44
ConfID: 5613481
CauseID: 1469723809
OtherID: 1469723808
JT: Annals of Oncology
MD: Hosono,28,,409,2017,Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
DOI: 10.1093/annonc/mdx376.016(Journal) (5613481-N)
DOI: 10.1093/annonc/mdx376.017(Journal)
==========================================================

Created: 2020-05-18 20:27:59
ConfID: 5613483
CauseID: 1469723821
OtherID: 1469723820
JT: Annals of Oncology
MD: Wang,28,,412,2017,Meta-Analysis of Anti-PD-1/PD-L1 Therapy Related Adverse Events in Clinical Trials
DOI: 10.1093/annonc/mdx376.025(Journal) (5613483-N)
DOI: 10.1093/annonc/mdx376.026(Journal)
==========================================================

Created: 2020-05-18 20:27:49
ConfID: 5613482
CauseID: 1469723813
OtherID: 1469723811
JT: Annals of Oncology
MD: Aamdal,28,,410,2017,Telomerase peptide vaccine combined with ipilimumab in metastatic melanoma: Reports from a phase I trial
DOI: 10.1093/annonc/mdx376.019(Journal) (5613482-N)
DOI: 10.1093/annonc/mdx376.020(Journal)
==========================================================

Created: 2017-08-09 00:01:35
ConfID: 5271874
CauseID: 1409918735
OtherID: 1409918726
JT: Annals of Oncology
MD: ,8,11,1055,1997,News
DOI: 10.1023/A:1017195131315(Journal) (5271874-N)
DOI: 10.1093/oxfordjournals.annonc.a010838(Journal)
DOI: 10.1093/oxfordjournals.annonc.a010839(Journal)
==========================================================

Created: 2020-01-08 00:14:35
ConfID: 5569748
CauseID: 1461053313
OtherID: 1409918806
JT: Annals of Oncology
MD: Betticher,8,11,1170,1997,Book review
DOI: 10.1023/A:1008282204404(Journal) (5569748-N)
DOI: 10.1093/oxfordjournals.annonc.a010842(Journal)
==========================================================

Created: 2020-01-08 00:18:26
ConfID: 5569749
CauseID: 1461053727
OtherID: 1402106720
JT: Annals of Oncology
MD: ,3,7,494,1992,News
DOI: 10.1093/oxfordjournals.annonc.a058248(Journal) (5569749-N)
DOI: 10.1016/S0923-7534(19)65284-1(Journal)
==========================================================

Created: 2020-01-07 22:28:24
ConfID: 5569744
CauseID: 1461045469
OtherID: 1461045468
JT: Annals of Oncology
MD: ,29,,49,2018,WITHDRAWN
DOI: 10.1093/annonc/mdy151.173(Journal) (5569744-N)
DOI: 10.1093/annonc/mdy151.172(Journal)
==========================================================

Created: 2020-01-07 18:08:20
ConfID: 5569733
CauseID: 1461029078
OtherID: 1461028985
JT: Annals of Oncology
MD: ,24,,7,2013,No Abstract Available
DOI: 10.1093/annonc/mdt042.1(Journal) (5569733-N)
DOI: 10.1093/annonc/mdt042.4(Journal)
DOI: 10.1093/annonc/mdt042.2(Journal)
DOI: 10.1093/annonc/mdt042.31(Journal)
DOI: 10.1093/annonc/mdt042.39(Journal)
DOI: 10.1093/annonc/mdt042.42(Journal)
DOI: 10.1093/annonc/mdt042.43(Journal)
DOI: 10.1093/annonc/mdt042.45(Journal)
DOI: 10.109
==========================================================

Created: 2020-01-07 20:20:27
ConfID: 5569740
CauseID: 1461037783
OtherID: 1461037777
JT: Annals of Oncology
MD: ,26,,13,2015,No abstract available
DOI: 10.1093/annonc/mdv087.2(Journal) (5569740-N)
DOI: 10.1093/annonc/mdv087.3(Journal)
==========================================================

Created: 2020-01-07 20:20:42
ConfID: 5569741
CauseID: 1461037797
OtherID: 1461037795
JT: Annals of Oncology
MD: ,26,,15,2015,No abstract available
DOI: 10.1093/annonc/mdv089.4(Journal) (5569741-N)
DOI: 10.1093/annonc/mdv089.1(Journal)
==========================================================

Created: 2020-01-07 22:26:44
ConfID: 5569743
CauseID: 1461045368
OtherID: 1461045365
JT: Annals of Oncology
MD: ,29,,31,2018,WITHDRAWN
DOI: 10.1093/annonc/mdy151.110(Journal) (5569743-N)
DOI: 10.1093/annonc/mdy151.112(Journal)
==========================================================

Created: 2020-01-07 20:19:22
ConfID: 5569736
CauseID: 1461037726
OtherID: 1461037724
JT: Annals of Oncology
MD: ,26,,2,2015,No abstract available
DOI: 10.1093/annonc/mdv080.1(Journal) (5569736-N)
DOI: 10.1093/annonc/mdv080.4(Journal)
DOI: 10.1093/annonc/mdv080.3(Journal)
==========================================================

Created: 2020-01-07 20:19:52
ConfID: 5569737
CauseID: 1461037748
OtherID: 1461037745
JT: Annals of Oncology
MD: ,26,,7,2015,No abstract available
DOI: 10.1093/annonc/mdv083.4(Journal) (5569737-N)
DOI: 10.1093/annonc/mdv083.3(Journal)
DOI: 10.1093/annonc/mdv083.1(Journal)
==========================================================

Created: 2020-01-07 20:20:12
ConfID: 5569738
CauseID: 1461037768
OtherID: 1461037766
JT: Annals of Oncology
MD: ,26,,10,2015,No abstract available
DOI: 10.1093/annonc/mdv085.5(Journal) (5569738-N)
DOI: 10.1093/annonc/mdv085.1(Journal)
==========================================================

Created: 2020-01-07 20:20:22
ConfID: 5569739
CauseID: 1461037779
OtherID: 1461037775
JT: Annals of Oncology
MD: ,26,,12,2015,No abstract available
DOI: 10.1093/annonc/mdv086.1(Journal) (5569739-N)
DOI: 10.1093/annonc/mdv086.4(Journal)
==========================================================

Created: 2020-01-09 17:37:38
ConfID: 5569905
CauseID: 1461227488
OtherID: 1461227486
JT: Annals of Oncology
MD: Tahara,23,,81,2012,Novel Development of EGFR-Targeted Agents for Head and Neck Cancer
DOI: 10.1016/S0923-7534(20)32183-9(Journal) (5569905-N)
DOI: 10.1016/S0923-7534(20)32184-0(Journal)
==========================================================

Created: 2020-01-09 17:43:03
ConfID: 5569906
CauseID: 1461227860
OtherID: 1461227859
JT: Annals of Oncology
MD: Morita,23,,131,2012,Association between Bevacizumab-Related Hypertension and VEGF Gene Polymorphisms in Japanese Colorectal Cancer Patients
DOI: 10.1016/S0923-7534(20)32379-6(Journal) (5569906-N)
DOI: 10.1016/S0923-7534(20)32378-4(Journal)